Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (2 active)

Company-led only

1 result

Therapy	Approach	Progress	Population	Additional Info
CIL001 (Paliroden) by CilcareCilcare SAS Compare	Small Molecule	Stage: Phase 1/2Status: Active	Adults · 45–75 yearsType 2 diabetes with speech-in-noise difficulty

Cilcare SAS · Small Molecule · Phase 1/2

ActiveTherapeuticStronger sources

Population

Adults · 45–75 years

Type 2 diabetes with speech-in-noise difficulty

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.